English (UK)
中文版YZtherapeutic Performance 
Project assessment, auditing, project management, regulatory affairs, quality, and IP management services
Dr. Yaacov Guy
CEOZhaoyou Investment 
2nd market PE,
about 300M RMB total value,
mainly focus on A-share market and startup on H-share market,
concentrating on high-speed developing industrials especially in Healthcare, including Big Biopharma/Superior Biotech companies.
about 300M RMB total value,
mainly focus on A-share market and startup on H-share market,
concentrating on high-speed developing industrials especially in Healthcare, including Big Biopharma/Superior Biotech companies.
Mr. Jasper Wu
Head of Research四川创新发展投资管理有限公司
四川创新发展投资管理有限公司（以下简称“川创投”）是一家主要从事股权投资及管理的专业机构,专注投资于自主创新高新技术企业、新兴产业企业和转型升级企业,投资范围涵盖生物医药、高端智能制造、TMT等重点行业领域。
川创投目前已承接管理了由四川省政府主导设立的四川省创新创业投资引导基金、四川省科技成果转化投资基金和四川省高层次人才创新创业投资基金等3支省级基金,在四川省全创区、China（绵阳）科技城、四川省自贸区和川南经济区先后布局6支区域子基金,并联合国内一线投资机构发起设立11支行业子基金,管理资本规模近100亿元,已初步形成深耕四川、覆盖全国的投资和服务网络。
川创投目前已承接管理了由四川省政府主导设立的四川省创新创业投资引导基金、四川省科技成果转化投资基金和四川省高层次人才创新创业投资基金等3支省级基金,在四川省全创区、China（绵阳）科技城、四川省自贸区和川南经济区先后布局6支区域子基金,并联合国内一线投资机构发起设立11支行业子基金,管理资本规模近100亿元,已初步形成深耕四川、覆盖全国的投资和服务网络。
言 喻
高级投资经理康宏耀源（天津）技术有限公司
The project focuses on the research and development of anti-tumor photosensitizing drugs for photodynamic therapy, creating a research and development technology platform for photosensitizing drugs, and conducting clinical development and transformation of anti-tumor photosensitizing drugs. The new anti-tumor photosensitizer drugs developed by our team exhibited excellent tumor enrichment and high efficacy of photodynamic therapy. They have great potential for clinical development and application.
Responsive Web Design powered by 